• 1
    De Francesco MA, Gargiulo F, Schreiber C, Ciravolo G, Salinaro F, Manca N. Detection and genotyping of human papillomavirus in cervical samples from Italian patients. J Med Virol 2005;75:58892.
  • 2
    Dalstein V, Riethmuller D, Pretet JL et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 2003;106:396403.
  • 3
    Munoz N, Bosch FX, De Sanjose S et al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:51827.
  • 4
    Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003;89:1015.
  • 5
    Stanczuk GA, Kay P, Allan B et al. Detection of human papillomavirus in urine and cervical swabs from patients with invasive cervical cancer. J Med Virol 2003;71:1104.
  • 6
    Ronco G, Ghisetti V, Segnan N et al. Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer 2005;41:297305.
  • 7
    Andersson S, Mints M, Sallstrom J, Wilander E. The relative distribution of oncogenic types of human papillomavirus in benign, pre-malignant and malignant cervical biopsies. A study with human papillomavirus deoxyribonucleic acid sequence analysis. Cancer Detect Prev 2005;29:3741.
  • 8
    Munoz N, Bosch FX, Castellsague X et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004;111:27885.
  • 9
    Lin H, Ma YY, Moh JS, Ou YC, Shen SY, ChangChien CC. High prevalence of genital human papillomavirus type 52 and 58 infection in women attending gynecologic practitioners in South Taiwan. Gynecol Oncol 2006;101:405.
  • 10
    An HJ, Cho NH, Lee SY et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 2003;97:167280.
  • 11
    Clavel C, Masure M, Putaud I et al. Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR results in cervical lesions. J Clin Pathol 1998;51:73740.
  • 12
    Kosel S, Burggraf S, Mommsen J, Engelhardt W, Olgemoller B. Type-specific detection of human papillomaviruses in a routine laboratory setting—improved sensitivity and specificity of PCR and sequence analysis compared to direct hybridisation. Clin Chem Lab Med 2003;41:78791.
  • 13
    Molijn A, Kleter B, Quint W, Van Doorn LJ. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 2005;32(Suppl. 1):S4351.
  • 14
    Bauer HM, Greer CE, Manos MM. Determination of genital human papillomavirus infection using consensus PCR. In: HerringtonCS, McGeeJOD, eds. Diagnostic molecular pathology: a practical approach. Oxford: Oxford University Press Inc, 1992:13252.
  • 15
    Saiki RK, Chang CA, Levenson CH et al. Diagnosis of sickle cell anemia and beta-thalassemia with enzymatically amplified DNA and nonradioactive allele-specific oligonucleotide probes. N Engl J Med 1988;319:53741.
  • 16
    De Villiers EM, Fauquet C, Broker TR, Bernard HU, Zur Hausen H. Classification of papillomaviruses. Virology 2004;324:1727.
  • 17
    Patti K, Kathleen M, Anna-Lise W. The use of nested polymerase chain reaction and restriction fragment length polymorphism for the detection and typing of mucosal human papillomaviruses in samples containing low copy numbers of viral DNA. J Virol Methods 2002;159:15970.
  • 18
    Stevens MP, Tabrizi SN, Quinn MA, Garland SM. Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Melbourne, Australia. Int J Gynecol Cancer 2006;16:101724.
  • 19
    Peedicayil A, Abraham P, Sathish N et al. Human papillomavirus genotypes associated with cervical neoplasia in India. Int J Gynecol Cancer 2006;16:15915.
  • 20
    Speich N, Schmitt C, Bollmann R, Bollmann M. Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: genotype spectrum of patients from the west German area. J Med Microbiol 2004;53:1258.
  • 21
    Venturoli S, Cricca M, Bonvicini F et al. Human papillomavirus DNA testing by PCR-ELISA and hybrid capture II from a single cytological specimen: concordance and correlation with cytological results. J Clin Virol 2002;25:17785.
  • 22
    Karlsen F, Kalantari M, Jenkins A et al. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol 1996;34:2095100.
  • 23
    Wu Y, Chen Y, Li L, Yu G, Zhang Y, He Y. Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol 2006;35:2649.
  • 24
    Ho CM, Chien TY, Huang SH, Lee BH, Chang SF. Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer. Gynecol Oncol 2006;102:5460.
  • 25
    Lo KW, Wong YF, Chan MK et al. Prevalence of human papillomavirus in cervical cancer: a multicenter study in China. Int J Cancer 2002;100:32731.
  • 26
    Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006;24(Suppl. 1):S115.
  • 27
    Masumoto N, Fujii T, Ishikawa M et al. Dominant human papillomavirus 16 infection in cervical neoplasia in young Japanese women; study of 881 outpatients. Gynecol Oncol 2004;94:50914.
  • 28
    An HJ, Kim KR, Kim IS et al. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study. Mod Pathol 2005;18:52834.
  • 29
    Chan PK, Li WH, Chan MY, Ma WL, Cheung JL, Cheng AF. High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions. J Med Virol 1999;59:2328.
  • 30
    Liaw KL, Hsing AW, Schiffman MH et al. Human papillomavirus types 52 and 58 are prevalent in cervical cancer from Chinese women. Int J Cancer 1997;73:7756.
  • 31
    Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:6373.
  • 32
    Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 2005;14:115764.
  • 33
    Bulkmans NW, Bleeker MC, Berkhof J, Voorhorst FJ, Snijders PJ, Meijer CJ. Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse. Int J Cancer 2005;117:17781.